Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Correction to “Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy”

Correction to “Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without... The Journal of Clinical Endocrinology & Metabolism, 2023, 108, e359 https://doi.org/10.1210/clinem/dgad067 Advance access publication 8 February 2023 Correction Correction to “Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy” In the above-named article by Ueland HO, Ulvik A, Løvås K, following thresholds of the ω statistics have been suggested Wolff ASB, Breivik LE, Stokland AEM, Rødahl E, Nilsen RM, for the strength of associations: ω less than 0.01 (very small); Husebye E, and Ueland GA (J Clin Endo Metab. 2023; doi: 0.01 less than or equal to ω less than 0.06 (small); 0.06 less 2 2 10.1210/clinem/dgad004), errors occurred in the Abstract, than or equal to ω less than 0.14 (medium); ω greater than Figure 2, and the text: or equal to 14 (large) (29).” The text should read: “The fol- In the Context section of the Abstract, this text was in- lowing thresholds of the ω statistics have been suggested cluded in error: “Objective, (then have to be changed to): for the strength of associations: ω less than 0.01 (very small); This work aimed to characterize the kynurenine pathway, ac- 0.01 less than or equal to ω and less than 0.06 (small); 0.06 2 2 tivated during interferon-γ mediated inflammation and cellu - less than or equal to ω and less than 0.14 (medium); ω great- lar (Th1-type) immunity, in GD patients with and without er than or equal to 0.14 (large) (29).” thyroid eye disease (TED).” The publisher acknowledges the errors. Figure 2 omitted this label below the x-axis: “Factor 2: Th1 cellular immunity.” The article has been corrected online. The following text appeared under the Statistical Analyses doi.org/10.1210/clinem/dgad004 heading of the Materials and Methods section: “The Corrected and Typeset: 8 February 2023 © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons. org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited. For commercial re-use, please contact [email protected] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of Clinical Endocrinology & Metabolism Oxford University Press

Correction to “Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy”

The Journal of Clinical Endocrinology & Metabolism , Volume 108 (6): 1 – Feb 8, 2023
Download PDF
1 page

Loading next page...
 
/lp/oxford-university-press/correction-to-systemic-activation-of-the-kynurenine-pathway-in-graves-j8WYaVOY0K

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Oxford University Press
Copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.
ISSN
0021-972X
eISSN
1945-7197
DOI
10.1210/clinem/dgad067
Publisher site
See Article on Publisher Site

Abstract

The Journal of Clinical Endocrinology & Metabolism, 2023, 108, e359 https://doi.org/10.1210/clinem/dgad067 Advance access publication 8 February 2023 Correction Correction to “Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy” In the above-named article by Ueland HO, Ulvik A, Løvås K, following thresholds of the ω statistics have been suggested Wolff ASB, Breivik LE, Stokland AEM, Rødahl E, Nilsen RM, for the strength of associations: ω less than 0.01 (very small); Husebye E, and Ueland GA (J Clin Endo Metab. 2023; doi: 0.01 less than or equal to ω less than 0.06 (small); 0.06 less 2 2 10.1210/clinem/dgad004), errors occurred in the Abstract, than or equal to ω less than 0.14 (medium); ω greater than Figure 2, and the text: or equal to 14 (large) (29).” The text should read: “The fol- In the Context section of the Abstract, this text was in- lowing thresholds of the ω statistics have been suggested cluded in error: “Objective, (then have to be changed to): for the strength of associations: ω less than 0.01 (very small); This work aimed to characterize the kynurenine pathway, ac- 0.01 less than or equal to ω and less than 0.06 (small); 0.06 2 2 tivated during interferon-γ mediated inflammation and cellu - less than or equal to ω and less than 0.14 (medium); ω great- lar (Th1-type) immunity, in GD patients with and without er than or equal to 0.14 (large) (29).” thyroid eye disease (TED).” The publisher acknowledges the errors. Figure 2 omitted this label below the x-axis: “Factor 2: Th1 cellular immunity.” The article has been corrected online. The following text appeared under the Statistical Analyses doi.org/10.1210/clinem/dgad004 heading of the Materials and Methods section: “The Corrected and Typeset: 8 February 2023 © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons. org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited. For commercial re-use, please contact [email protected]

Journal

The Journal of Clinical Endocrinology & Metabolism – Oxford University Press

Published: Feb 8, 2023

There are no references for this article.